Royce & Associates LP Artivion, Inc. Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

A detailed history of Royce & Associates LP transactions in Artivion, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 871,170 shares of AORT stock, worth $24.9 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

871,170

Previous 1,004,380 13.26%

Holding current value

$24.9 Million

Previous $25.8 Million 9.98%

% of portfolio

0.22%

Previous 0.25%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$24.33 - $28.46 $3.24 Million - $3.79 Million	-133,210 Reduced 13.26%	871,170 $23.2 Million
Q2 2024 Aug 13, 2024	SELL	$19.62 - $25.65 $2.26 Million - $2.96 Million	-115,241 Reduced 10.29%	1,004,380 $25.8 Million
Q1 2024 May 13, 2024	BUY	$16.7 - $21.63 $583,113 - $755,254	34,917 Added 3.22%	1,119,621 $23.7 Million
Q4 2023 Feb 12, 2024	BUY	$12.33 - $18.83 $1.19 Million - $1.82 Million	96,700 Added 9.79%	1,084,704 $19.4 Million
Q3 2023 Nov 09, 2023	BUY	$14.82 - $17.52 $578,869 - $684,331	39,060 Added 4.12%	988,004 $15 Million
Q2 2023 Aug 07, 2023	SELL	$12.78 - $17.23 $150,650 - $203,107	-11,788 Reduced 1.23%	948,944 $16.3 Million
Q1 2023 May 04, 2023	BUY	$11.74 - $14.12 $1.35 Million - $1.62 Million	115,000 Added 13.6%	960,732 $12.6 Million
Q4 2022 May 23, 2023	SELL	$10.01 - $13.9 $1.15 Million - $1.6 Million	-115,000 Reduced 11.97%	845,732 $10.3 Million
Q4 2022 Feb 13, 2023	SELL	$10.01 - $13.9 $760,760 - $1.06 Million	-76,000 Reduced 8.25%	845,732 $10.3 Million
Q3 2022 Nov 03, 2022	BUY	$13.31 - $23.25 $834,537 - $1.46 Million	62,700 Added 7.3%	921,732 $12.8 Million
Q2 2022 Aug 04, 2022	BUY	$15.73 - $22.91 $9.88 Million - $14.4 Million	628,300 Added 272.31%	859,032 $16.2 Million
Q1 2022 May 05, 2022	BUY	$16.95 - $21.74 $63,257 - $81,133	3,732 Added 1.64%	230,732 $4.93 Million
Q4 2021 Feb 07, 2022	SELL	$17.19 - $22.84 $85,950 - $114,200	-5,000 Reduced 2.16%	227,000 $4.62 Million
Q2 2021 Aug 06, 2021	SELL	$22.32 - $32.07 $774,504 - $1.11 Million	-34,700 Reduced 13.01%	232,000 $6.59 Million
Q1 2021 May 10, 2021	SELL	$22.07 - $26.31 $2.02 Million - $2.41 Million	-91,458 Reduced 25.54%	266,700 $6.02 Million
Q3 2020 Nov 12, 2020	BUY	$16.35 - $21.4 $2.17 Million - $2.84 Million	132,900 Added 59.0%	358,158 $6.62 Million
Q2 2020 Aug 07, 2020	BUY	$16.34 - $25.24 $393,238 - $607,425	24,066 Added 11.96%	225,258 $4.32 Million
Q1 2020 May 12, 2020	SELL	$14.66 - $30.57 $590,299 - $1.23 Million	-40,266 Reduced 16.68%	201,192 $3.4 Million
Q4 2019 Feb 06, 2020	SELL	$22.45 - $27.09 $5.63 Million - $6.8 Million	-250,859 Reduced 50.95%	241,458 $6.54 Million
Q3 2019 Nov 13, 2019	BUY	$25.98 - $30.8 $845,571 - $1 Million	32,547 Added 7.08%	492,317 $13.4 Million
Q2 2019 Aug 12, 2019	BUY	$27.55 - $32.39 $2.43 Million - $2.86 Million	88,353 Added 23.79%	459,770 $13.8 Million
Q1 2019 May 09, 2019	BUY	$25.85 - $30.47 $2.46 Million - $2.9 Million	95,109 Added 34.42%	371,417 $10.8 Million
Q4 2018 Feb 11, 2019	SELL	$25.76 - $34.03 $210,871 - $278,569	-8,186 Reduced 2.88%	276,308 $7.84 Million
Q3 2018 Nov 13, 2018	SELL	$28.6 - $35.75 $1.86 Million - $2.32 Million	-64,900 Reduced 18.58%	284,494 $10 Million
Q2 2018 Aug 09, 2018	SELL	$19.4 - $29.35 $673,180 - $1.02 Million	-34,700 Reduced 9.03%	349,394 $9.73 Million
Q1 2018 May 14, 2018	SELL	$16.85 - $22.1 $62,429 - $81,880	-3,705 Reduced 0.96%	384,094 $7.7 Million
Q4 2017 Feb 09, 2018	SELL	$18.65 - $23.85 $182,993 - $234,016	-9,812 Reduced 2.47%	387,799 $7.43 Million
Q3 2017 Nov 13, 2017	SELL	$18.85 - $23.05 $708,552 - $866,426	-37,589 Reduced 8.64%	397,611 $9.03 Million
Q2 2017 Aug 07, 2017	BUY	N/A	435,200	435,200 $8.68 Million

Others Institutions Holding AORT

# of Institutions

174

Shares Held

35.8M

Call Options Held

33K

Put Options Held

900

View Full List

About ARTIVION, INC.

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.15B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

More about AORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Artivion, Inc. Transaction History